What is the equity of Ceapro this year?
Ceapro has equity of 27.86 M CAD this year.
Ceapro Equity 2024
Ceapro Equity
27.86 M CAD
Ticker
CZO.V
ISIN
CA1499071076
WKN
931278
In 2024, Ceapro's equity was 27.86 M CAD, a -13.73% increase from the 32.29 M CAD equity in the previous year.
Ceapro Aktienanalyse
What does Ceapro do?
Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Ceapro's Equity
Ceapro's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ceapro's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Ceapro's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Ceapro's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Ceapro’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Ceapro stock
What was the equity of Ceapro compared to the previous year?
The equity of Ceapro has increased/decreased by -13.73% decreased compared to the previous year.
What impact does a high equity have on investors of Ceapro?
A high equity is advantageous for investors of Ceapro as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Ceapro?
A low equity can be a risk for investors of Ceapro, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Ceapro affect the company?
An increase in equity of Ceapro can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Ceapro affect the company?
A reduction in equity of Ceapro can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Ceapro?
Some factors that can affect the equity of Ceapro include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Ceapro so important for investors?
The equity of Ceapro is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Ceapro take to change the equity?
To change equity, Ceapro can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Ceapro pay?
Over the past 12 months, Ceapro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ceapro is expected to pay a dividend of 0 CAD.
What is the dividend yield of Ceapro?
The current dividend yield of Ceapro is .
When does Ceapro pay dividends?
Ceapro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ceapro?
Ceapro paid dividends every year for the past 0 years.
What is the dividend of Ceapro?
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ceapro located?
Ceapro is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Ceapro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ceapro from 8/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 8/20/2024.
When did Ceapro pay the last dividend?
The last dividend was paid out on 8/20/2024.
What was the dividend of Ceapro in the year 2023?
In the year 2023, Ceapro distributed 0 CAD as dividends.
In which currency does Ceapro pay out the dividend?
The dividends of Ceapro are distributed in CAD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ceapro
Our stock analysis for Ceapro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ceapro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
